Concerto Biosciences
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $48M
Investors
- 5
About Concerto Biosciences
Concerto Biosciences Inc.Founded in 2020 and headquartered in Boston, US, Concerto Biosciences specializes in microbial technology applications.Concerto Biosciences specializes in leveraging microbial communities to develop innovative solutions for various applications, including skincare, chronic disease management, and nutrition. Their core offerings are driven by the kChip platform, which generates extensive ecological datasets that inform product development. The kAI model enhances these efforts by mapping microbial interactions and predicting their behavior, resulting in engineered microbial products that are applicable in real-world settings. Concerto’s products aim to address complex issues in consumer health and wellness, serving a diverse clientele that includes skincare manufacturers, healthcare providers, and nutritional product companies.Concerto Biosciences operates through a revenue model that emphasizes partnerships and direct client relationships, particularly with businesses in the healthcare and consumer goods sectors. The company engages in business-to-business transactions, collaborating with manufacturers and distributors to integrate its microbial solutions into their product lines. Clients benefit from the tailored application of Concerto's technology to enhance their offerings.In November 2022, Concerto Biosciences Inc. Concerto aims to introduce new products that address emerging needs in the skincare and healthcare sectors, targeting release by late 2023, and is exploring expansion into additional markets across Europe and Asia by 2024.
Who invested in Concerto Biosciences
5 investors across 4 rounds
See all investors in Concerto Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Concerto Biosciences
Who invested in Concerto Biosciences?
Concerto Biosciences has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Concerto Biosciences raised?
Concerto Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Concerto Biosciences last raise money?
Concerto Biosciences's most recent round on record is a Series A, in Nov 2022.
What does Concerto Biosciences do?
Concerto Biosciences is a biotechnology company.
Where is Concerto Biosciences headquartered?
Concerto Biosciences is headquartered in Boston, US.
Which VCs invest in companies like Concerto Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Concerto Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Concerto Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.